1. Efficacy and Safety of Bempedoic Acid + Ezetimibe Fixed-Dose Combination in Patients at High CVD Risk and with Elevated LDL-C Receiving Maximally Tolerated Statin Therapy. (August 2019) Authors: Ballantyne, C.; Laufs, U.; Ray, K.K.; Leiter, L.A.; Bays, H.E.; Goldberg, A.C.; Stroes, E.S.G.; MacDougall, D.; Zhao, X.; Catapano, A.L. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evinacumab markedly reduces low-density lipoprotein cholesterol in adolescent patients with homozygous familial hypercholesterolemia. (August 2021) Authors: Reeskamp, L.F.; Greber-Platzer, S.; Saheb, S.; Stefanutti, C.; Stroes, E.S.G.; Ali, S.; Banerjee, P.; Pordy, R.; Zhao, J.; Raal, F.J. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extremely elevated lipoprotein(a) levels are largely undetected but associated with a very high cardiovascular disease risk in a hospital population. (August 2021) Authors: Nurmohamed, N.S.; Kaiser, Y.; Schuitema, P.C.E.; Nierman, M.; Fischer, J.C.; Stroes, E.S.G. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification and management of canadian patients with symptoms of statin intolerance: Results from a real-world clinical practice survey. (September 2016) Authors: Oh, P.; Hovingh, G.K.; Gandra, S.R.; McKendrick, J.; Dent, R.; Wieffer, H.M.; Catapano, A.L.; Rosenson, R.S.; Stroes, E.S.G. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ldl-Cholesterol Lowering Treatment Changes Hematopoietic Stem Cell Behavior In Familial Hypercholesterolemia Patients. (August 2019) Authors: Stiekema, L.; Zeerleder, S.S.; Homburg, C.H.; Voermans, C.; Stroes, E.S.G.; Kroon, J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lipoprotein(A) is associated with increased calcification and disease progression in aortic stenosis patients. (August 2018) Authors: Zheng, K.h.; Pawade, T.; Kroon, J.; Hjortnaes, J.; Verbeek, R.; Arsenault, B.J.; Rogers, M.A.; Aikawa, E.; Stroes, E.S.G.; Tsimikas, S.; Boekholdt, S.M.; Dweck, M.R. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lipoprotein(a) is not associated with active calcification assessed with 18F-NaF PET/CT in patients with mild to moderate aortic valve stenosis. (August 2021) Authors: Kaiser, Y.; Nurmohamed, N.S.; Kroon, J.; Verberne, H.J.; Tzolos, E.; Dweck, M.R.; Somsen, A.G.; Arsenault, B.; Stroes, E.S.G.; Zheng, K.H.; Boekholdt, S.M. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lp(A)-Induced Metabolic Activity In Valve Interstitial Cells Drives Inflammation And Ultimately Calcification. (August 2019) Authors: Ali, L.; Zheng, K.H.; Schnitzler, J.G.; Hjortnaes, J.; Stroes, E.S.G.; Kroon, J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Persistent monocyte activation in patients with elevated LDL cholesterol levels during statin treatment. (August 2018) Authors: Bekkering, S.; Bernelot-Moens, S.J.; Verweij, S.L.; Stiekema, L.C.A.; Roeters-van Lennep, J.; Joosten, L.A.B.; Netea, M.G.; Stroes, E.S.G.; Riksen, N.P. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Plasma apolipoprotein CIII levels and incident coronary artery disease risk: The EPIC-Norfolk prospective population study. (September 2016) Authors: van Capelleveen, J.; Moens, S.J. Bernelot; Yang, X.; Wareham, N.T.; Khaw, K.T.; Stroes, E.S.G.; Witztum, J.L.; Hovingh, G.K.; Boekholdt, S.M.; Tsimikas, S. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗